» Articles » PMID: 26716113

Please Provide Us with a Reasonable Definition for Curative R0 Resection in Barrett's Esophagus Neoplasia; Which One Should We Choose?

Overview
Journal Endosc Int Open
Specialty Gastroenterology
Date 2015 Dec 31
PMID 26716113
Authors
Affiliations
Soon will be listed here.
References
1.
Manner H, Pech O, Heldmann Y, May A, Pauthner M, Lorenz D . The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2014; 29(7):1888-96. DOI: 10.1007/s00464-014-3881-3. View

2.
Montgomery E, Bronner M, Goldblum J, Greenson J, Haber M, Hart J . Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001; 32(4):368-78. DOI: 10.1053/hupa.2001.23510. View

3.
Manner H, May A, Pech O, Gossner L, Rabenstein T, Gunter E . Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol. 2008; 103(10):2589-97. DOI: 10.1111/j.1572-0241.2008.02083.x. View

4.
Shaheen N, Sharma P, Overholt B, Wolfsen H, Sampliner R, Wang K . Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009; 360(22):2277-88. DOI: 10.1056/NEJMoa0808145. View

5.
Fitzgerald R, di Pietro M, Ragunath K, Ang Y, Kang J, Watson P . British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2013; 63(1):7-42. DOI: 10.1136/gutjnl-2013-305372. View